Family summary
Historical shortage references are available across related Etoposide presentations from multiple manufacturers.
- 0 current shortage context pages.
- 11 historical shortage context pages.
- 4 manufacturers represented.
Etoposide - Drug Shortage Information
Public shortage context is available across 11 visible exact NDC pages for this generic drug family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Etoposide 20 mg / mL Injection 25 mL - NDC 16729-0114-08Accord Healthcare Inc. | 1 Vial, Multi-DoseEtoposide 20 mg / mL Injection 50 mL - NDC 16729-0114-11Accord Healthcare Inc. | 1 Vial, Multi-DoseEtoposide 20 mg / mL Injection 5 mL - NDC 16729-0114-31Accord Healthcare Inc. | 1 Vial, Multi-DoseEtoposide 20 mg / mL Injection 5 mL - NDC 68001-0265-25BluePoint Laboratories | 1 Vial, Multi-DoseEtoposide 20 mg / mL Injection 5 mL - NDC 63323-0104-05Fresenius Kabi USA, LLC | 10 Box
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.